Characteristics of plasma NOx levels in severe sepsis: High interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels

Clinical Endocrinology

Volumn 73, Issue 3, 2010, Pages 413-420

  Ho, Jui T ^a,b   Chapman, M J ^a   O'Connor, S ^a   Lam, S ^a   Edwards, J ^a   Ludbrook, G ^a   Lewis, J G ^c   Torpy, D J ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; HYDROCORTISONE; HYPERTENSIVE FACTOR; NITRIC OXIDE; NITRIC OXIDE METABOLITE; NORADRENALIN; TRANSCORTIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PLASMA CHARACTERISTICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; STANDARD;

ANALYSIS OF VARIANCE; DOBUTAMINE; EPINEPHRINE; FEMALE; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; NOREPINEPHRINE; PROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS; TRANSCORTIN; VASOCONSTRICTOR AGENTS;

EID: 77955734986     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03817.x     Document Type: Article

References (43)

1. Moss, M. Martin, G.S. (2004) A global perspective on the epidemiology of sepsis. Intensive Care Medicine, 30, 527 529.
2. Vincent, J.L., Gris, P., Coffernils, M. et al. (1992) Myocardial depression characterizes the fatal course of septic shock. Surgery, 111, 660 667.
3. Groeneveld, A.B., Nauta, J.J. Thijs, L.G. (1988) Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Medicine, 14, 141 147.
4. Julou-Schaeffer, G., Gray, G.A., Fleming, I. et al. (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. American Journal of Physiology, 259, H1038 H1043.
5. Laszlo, F., Whittle, B.J., Evans, S.M. et al. (1995) Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. European Journal of Pharmacology, 283, 47 53.
6. Brady, A.J., Poole-Wilson, P.A., Harding, S.E. et al. (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. American Journal of Physiology, 263, H1963 H1966.
7. Vincent, J.L., Zhang, H., Szabo, C. et al. (2000) Effects of nitric oxide in septic shock. American Journal of Respiratory and Critical Care Medicine, 161, 1781 1785.
8. Spack, L., Havens, P.L. Griffith, O.W. (1997) Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Critical Care Medicine, 25, 1071 1078.
9. Krafte-Jacobs, B., Brilli, R., Szabo, C. et al. (1997) Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Critical Care Medicine, 25, 1588 1593.
10. Wong, H.R., Carcillo, J.A., Burckart, G. et al. (1995) Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome. Critical Care Medicine, 23, 835 842.
11. Ochoa, J.B., Udekwu, A.O., Billiar, T.R. et al. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Annals of Surgery, 214, 621 626.
12. Doughty, L., Carcillo, J.A., Kaplan, S. et al. (1998) Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis. Critical Care Medicine, 26, 157 162.
13. Petros, A., Lamb, G., Leone, A. et al. (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovascular Research, 28, 34 39.
14. Lopez, A., Lorente, J.A., Steingrub, J. et al. (2004) Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Critical Care Medicine, 32, 21 30.
15. Bakker, J., Grover, R., McLuckie, A. et al. (2004) Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Critical Care Medicine, 32, 1 12.
16. Yang, S. Zhang, L. (2004) Glucocorticoids and vascular reactivity. Current Vascular Pharmacology, 2, 1 12.
17. Sapolsky, R.M., Romero, L.M. Munck, A.U. (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions Endocrine Reviews, 21, 55 89.
18. Marik, P.E., Pastores, S.M., Annane, D. et al. (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine, 36, 1937 1949.
19. Annane, D., Sebille, V., Charpentier, C. et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 288, 862 871.
20. Chawla, K., Kupfer, Y. Tessler, S. (2000) Prognostic value of cortisol response in septic shock. JAMA, 284, 309.
21. Bollaert, P.E., Charpentier, C., Levy, B. et al. (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Critical Care Medicine, 26, 645 650.
22. Briegel, J., Forst, H., Haller, M. et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Critical Care Medicine, 27, 723 732.
23. Sprung, C.L., Annane, D., Keh, D. et al. (2008) Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine, 358, 111 124.
24. Keh, D., Boehnke, T., Weber-Cartens, S. et al. (2003) Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. American Journal of Respiratory and Critical Care Medicine, 167, 512 520.
25. -(1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 20, 864 874.
26. Knaus, W.A., Draper, E.A., Wagner, D.P. et al. (1985) APACHE II: a severity of disease classification system. Critical Care Medicine, 13, 818 829.
27. Ho, J.T., Al-Musalhi, H., Chapman, M.J. et al. (2006) Septic shock and sepsis: a comparison of total and free plasma cortisol levels. Journal of Clinical Endocrinology and Metabolism, 91, 105 114.
28. Aird, W.C. (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood, 101, 3765 3777.
29. Nathan, C. Xie, Q.W. (1994) Regulation of biosynthesis of nitric oxide. Journal of Biological Chemistry, 269, 13725 13728.
30. Zamora, R., Vodovotz, Y. Billiar, T.R. (2000) Inducible nitric oxide synthase and inflammatory diseases. Molecular Medicine, 6, 347 373.
31. Kirkeboen, K.A. Strand, O.A. (1999) The role of nitric oxide in sepsis - an overview. Acta Anaesthesiologica Scandinavica, 43, 275 288.
32. Hollenberg, S.M., Cunnion, R.E. Zimmerberg, J. (1993) Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. American Journal of Physiology, 264, H660 H663.
33. Sundrani, R., Easington, C.R., Mattoo, A. et al. (2000) Nitric oxide synthase inhibition increases venular leukocyte rolling and adhesion in septic rats. Critical Care Medicine, 28, 2898 2903.
34. Ferrari, P. (2003) Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease. Best Practice and Research. Clinical Endocrinology and Metabolism, 17, 575 589.
35. Sakaue, M. Hoffman, B.B. (1991) Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. Journal of Clinical Investigation, 88, 385 389.
36. Radomski, M.W., Palmer, R.M. Moncada, S. (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 10043 10047.
37. Whitworth, J.A., Schyvens, C.G., Zhang, Y. et al. (2002) The nitric oxide system in glucocorticoid-induced hypertension. Journal of Hypertension, 20, 1035 1043.
38. MacKenzie, I.M., Garrard, C.S. Young, J.D. (2001) Indices of nitric oxide synthesis and outcome in critically ill patients. Anaesthesia, 56, 326 330.
39. Sakurai, H., Kohsaka, H., Liu, M.F. et al. (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. Journal of Clinical Investigation, 96, 2357 2363.
40. Salter, M., Knowles, R.G. Moncada, S. (1991) Widespread tissue distribution, species distribution and changes in activity of Ca(2 +)-dependent and Ca(2 +)-independent nitric oxide synthases. FEBS Letters, 291, 145 149.
41. Cunha, F.Q., Assreuy, J., Moss, D.W. et al. (1994) Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology, 81, 211 215.
42. Annane, D., Sanquer, S., Sebille, V. et al. (2000) Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet, 355, 1143 1148.
43. Schoedon, G., Schneemann, M., Walter, R. et al. (1995) Nitric oxide and infection: another view. Clinical Infectious Diseases, 21 (Suppl 2 S152 S157.